PAR 4.84% 29.5¢ paradigm biopharmaceuticals limited..

Ann: Investor Presentation - $66m Capital Raise, page-76

  1. 4,232 Posts.
    lightbulb Created with Sketch. 6717
    Kiwinvestor, there have been at least a couple, the most prominent in my mind is the donkey study. There was one also performed on MPS rats which was pretty amazing.

    These excerpts from the Donkey study duly referenced below for your reading pleasure:


    "This study confirms the previous reports on repair of articular
    cartilage in the horses. Among these studies, it is generally accepted
    that articular cartilage has limited reparative powers".



    "These data clearly demonstrate the ability of PPS to stimulate the
    biosynthesis of components of the extracellular matrix accompanied by
    limiting their degradation by its anticatabolic effects".




    https://irp-cdn.multiscreensite.com/d048e3f1/files/uploaded/JT%20-%20Pentosan-polysulfate-as-a-disease-modifier.pdf



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.015(4.84%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.5¢ 30.5¢ 29.5¢ $86.19K 286.7K

Buyers (Bids)

No. Vol. Price($)
4 70151 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 18600 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.